founders

Maddalena Adorno, Ph.D.

image1

Chief Executive Officer


Dr. Adorno holds a M.Sc. in Medical Biotechnology and a Ph.D. in Biomedicine and Cancer Biology. She did her post-doctoral research at Stanford School of Medicine and worked there as Research Fellow until 2018. She has fifteen years of experience in cancer biology, stem cells, and aging. She has publications in Nature, Cell, and Science and she is an inventor on several international patents.


madda@doriantherapeutics.com

Benedetta di Robilant, Ph.D.

image2

 Chief Scientific Officer


Dr. di Robilant obtained her Ph.D. in basic and applied immunotherapy at San Raffaele University in Milan, where she became an expert in CAR-T cells and antigen validation. She worked as a postdoctoral fellow at Stanford University Medical School until 2018 where she focused on aging, senescence and stem cell self-renewal.




benedetta@doriantherapeutics.com

Dorian scientific team

Hazal Pektas, M.S.

image3

Research Associate

University of California San Francisco

Katya Nikolov, MD, Ph.D.

image4

Assay Development Scientist

Memorial Sloan-Kettering Cancer Center 

Cornell University (PostDoc)

Russian National Research Medical University (MD)

Hiring!

image5

- Director of Research

- Senior scientists

-Research associates


Johanna Lena Theruvath, M.D., Ph.D.

image6

Consultant

Postdoctoral fellow at Stanford University

Sara Cipolat, Ph.D.

image7

Consultant

Founder, Karyon Life Sciences

Cambridge Cancer Research Institute (PostDoc)

Samuele Marro, Ph.D.

image8

Consultant

Postdoctoral fellow at Stanford University

Dorian Strategic partners

Michelle Arkin, Ph.D.

image9

Professor, Pharmaceutical Chemistry at UCSF

Faculty Co-director, Small Molecule Discovery Center (SMDC) at UCSF

Franco Marincola, M.D.

image10


CSO at Refuge Biotechnology

Distinguished Research Fellow at AbbVie Inc.

Chief Infectious Disease and Immunogenetics (NIH)